Delivery Order SPE2DX22D0010-SPE2D825FJF30
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,497.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of MS Continuous Release Tablets 30mg, with an ultimate completion date of July 31, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that serves...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Morphine Sulfate 60 mg tablets in quantities of 100, with a ceiling value of $1,130.76. This firm fixed-price delivery order is scheduled for completion by September 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, reflecting AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 20, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This is a firm fixed-price delivery order, classified as a child contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract has an ultimate completion...
- The Defense Logistics Agency awarded a $1,270.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Morphine Sulfate 4 mg/mL in vial format, with completion scheduled for August 8, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) on August 24, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 5, 2025, for the supply of OxyContin Tablets 30mg to the Defense Logistics Agency's Medical Supply Chain. The contract, valued at $1,541.40 with a firm fixed-price structure, carries an ultimate completion date of August 6, 2025, and will be fulfilled at the vendor's Conshohocken, PA facility. This delivery order was competitively awarded with no...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,194.12 on August 14, 2025, for OxyContin ER 30 mg tablets (100-count supply). This firm fixed price, non-set-aside contract is part of AmerisourceBergen's broader engagement with the DLA and represents a delivery order issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- This federal contract award, valued at $1,204.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MS CONTIN ER 30 MG TABLET 100S, a prescription pain medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, designated as SPE2DX, which has a ceiling value of $999,999,999.00. This IDC...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for OxyContin ER 30 mg tablets (100-count units) with a ceiling value of $1,717.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of OxyContin tablets 40mg, with a contract ceiling value of $2,508.63 and an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJF30Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of MS Contin Tabs 30mg, a morphine sulfate pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $8.6K and is scheduled for completion by September 10, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $1 billion through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company's extensive portfolio with DLA encompasses a wide range of medications and medical supplies spanning multiple therapeutic domains, positioning it as a critical vendor for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/9/25 |